Leonteq Securities »

Tvardi Therapeutics shares owned by Leonteq Securities

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Leonteq Securities from 13F filings

Historical chart of Leonteq Securities investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Leonteq Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Leonteq Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $51 12 4.33

More positions owned by Leonteq Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Meta Platforms Cl A Put Option (META)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Stellantis SHS (STLA)
Micron Technology (MU)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Put Option (MSFT)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Citigroup Com New Put Option (C)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)

View all positions for Leonteq Securities

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
FMR
Duncan Williams Asset Management
Squarepoint Ops
Northern Trust
Jane Street
Farallon Capital Management
UBS Group
Goldman Sachs Group

View all funds holding Tvardi Therapeutics